HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Non-Hodgkin's lymphomas of the gastrointestinal tract. An evaluation of paraffin section immunostaining.

Abstract
Although the gastrointestinal (GI) tract is the most common site of primary extranodal lymphomas, the lineage of these tumors has been controversial. The authors used paraffin-reactive antibodies detecting markers of B-, T-, histiocytic, and epithelial cells to study 34 non-Hodgkin's lymphomas of the GI tract for which unequivocal frozen-section immunophenotypine was available as a control to determine whether these antibodies are reliable in the study of these tumors. Frozen-section studies revealed 31 tumors of B-cell origin and three T-cell tumors. Paraffin-reactive antibodies confirmed B-cell lineage in 28 of the 31 cases, with equivocal results in the remaining three. Only one of the T-cell lymphomas was identified in paraffin studies. Our results indicate that paraffin-reactive antibodies can reliably identify most B-cell lymphomas in the GI tract but may be unreliable in the detection of lymphomas of T-cell origin.
AuthorsB C Wolf, A W Martin, H J Ree, P M Banks, S Smith, R S Neiman
JournalAmerican journal of clinical pathology (Am J Clin Pathol) Vol. 93 Issue 2 Pg. 233-9 (Feb 1990) ISSN: 0002-9173 [Print] England
PMID1689097 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antigens, Neoplasm
  • Paraffin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Neoplasm (analysis)
  • B-Lymphocytes (pathology)
  • Evaluation Studies as Topic
  • Female
  • Frozen Sections
  • Gastrointestinal Neoplasms (metabolism, pathology)
  • Humans
  • Immunoenzyme Techniques
  • Lymphoma, Non-Hodgkin (metabolism, pathology)
  • Male
  • Middle Aged
  • Paraffin
  • Phenotype
  • Pilot Projects
  • Retrospective Studies
  • Staining and Labeling
  • T-Lymphocytes (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: